Globally, the COVID-19 pandemic has shown a positive impact on the market growth, with the rapid development of diagnostics, fast-tracked regulatory clearances, and ramped up distribution in various countries to help curb the spread of the virus. Various diagnostics procedures have always been essential in the detection of infectious diseases. Currently, a number of molecular assays and immunoassays are in place to detect COVID-19.

For instance, in July 2020, Roche launched Cobas 8800 instrument at the National Institute of Cholera and Enteric Diseases, Kolkata, India, and Cobas 6800 at the National Institute for Research in Reproductive Health, Mumbai, India to aid with SARS CoV-2 diagnostic testing. Roche’s Cobas 6800/8800 systems provide test results in three and half hours and offer flexibility, improved operating efficiency, and fastest time-to-time results.

Globally, genomic technologies are increasingly being used to understand and contribute in the development of new diagnostic tests or procedures for various diseases which is boosting the market growth. For instance, Tata Medical and Diagnostics in collaboration with Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology launched new diagnostic testing for Covid-19 in November 2020 in India.

Furthermore, technological advancements associated with sequencing technologies, chromatography methods, mass spectrometry, and other products led to the increasing adoption of these tools in hospitals, research, and diagnostic laboratories. For instance, according to a research study by Malin Källsten et al., published in Analytical and Bioanalytical Chemistry Journal 2019, mass spectrometry helps in the characterization of antibody–drug conjugates in the development of new medicines.

According to the World Health organization (WHO) 2020 Factsheet, there were around 38.0 million people with HIV in 2019. In addition, about 68% of adults and 53% of children had HIV globally. Thus, high patient population will boost the demand for treatment and which further increase use of life sciences tools for identifying, diagnosing, and monitoring the progression of several infectious diseases.

Furthermore, increasing demand for diagnostic tests for many infectious diseases will also promote the growth of life science tools for diagnosing the target population and drive the overall market growth over the forecast period.

Free Sample report for this report is available :- https://www.statzyreports.com/report/sr497993/life-science-tools-market

Key Market Trends

Life Science Tools in Separation Technologies is Estimated to Witness a Healthy Growth Rate Over the Forecast Period.

The major factors driving the separation technologies segment include growing investments in pharmaceutical R&D and increasing adoption of chromatography technologies by the life sciences industries.

Globally, the COVID-19 pandemic has shown a positive impact on the life science tools market. The outbreak of COVID-19 in 2020 has resulted in an increased patient pool, leading to a subsequent surge in R&D activities. Increasing investments in drug discovery are thus, expected to fuel the growth of the separation technologies segment.

For instance, in March 2020, The CARES Act had been passed in the United States that contains several provisions related to the production and development of products in response to the COVID-19 global pandemic. This act provided a provision of USD 3.5 billion to the Biomedical Advanced Research and Development Authority (BARDA) to fund the manufacturing and production of vaccines.

The separation technologies comprise immunoprecipitation, chromatography techniques, automated purification systems, and others that helps in the diagnosis and treatment of COVID-19. For instance, according to a research article by Ankesh Gupta et al., publsihed in Indian Journal of Medical Research 2020, the study was conducted at a tertiary care teaching hospital in north India to assess rapid chromatographic immunoassay-based test in the diagnosis of COVID-19. The study results found that rapid chromatographic immunoassay-based test can help in quick detection, isolation and treatment of COVID-19 patients.

Furthermore, this technology is widely adopted by several industries due to several benefits associated with the chromatography technology. Advantages such as reducing the need for large-scale column which increases the efficiency and productivity of manufacturing process. Thus, increasing the adoption of several separation technologies around various sectors will boost the demand for life science tools and promotes the segment growth.

In addition, the rising prevalence of infectious diseases across the globe will promote the adoption of life science tools. For instance, according to the Tuberculosis Surveillance Center in 2019 there were 14,460 patients of tuberculosis were notified in Japan. The notification rate of all forms of tuberculosis was 11.5 per 100,000 population. It has been persistently declining for the past years, however, it is still at a far higher level than compared to other industrialized countries. Thus, owing to above mentioned factors it is expected to drive segment growth over the forcast period.

North America is Expected to Hold a Significant Market Share Over the Forecast Period

The major factors driving the market growth in the North American region include the rising number of genomic procedures, increasing research and development expenditure, the presence of a large number of major players, growing adoption among biopharmaceutical companies, product launches, and technological advancements.

With the outbreak of COVID-19 in 2020 in the United States, there is an increasing diagnostics procedures that are driving the market growth. Thus, diagnostic procedures with new technologies have proved to be beneficial in managing COVID-19 and driving the life sciences tools market growth.

In the United States, the biopharmaceutical industry has grown substantially to include novel product types such as synthetic vaccines, nanobodies, rDNA, fusion proteins, immunoconjugates, soluble receptor,s and immunotherapeutics. The rise in investments by pharmaceutical and biopharmaceutical industries in R&D related to life sciences tools research and academics are expected to drive the market.

For instance, as per Pharmaceutical Research and Manufacturers of America (PhRMA), the United States biopharmaceutical industry has been one of the world leader in the development of new medicines. The entire biopharmaceutical and pharmaceutical industry invested an estimated USD 83 billion in research and development (R&D) in 2019 compared to 2018 which was around USD 83 billion invested in research and development (R&D).​

The market players in North America region are adopting various strategies such as developing and launching new products, partnerships, collaborations and expansions which may drive the market growth. For instance, in February 2019, Danaher Corporation entered into an agreement with GE Healthcare. Under the agreement, Danaher Corporation will acquire the biopharma business of GE Healthcare.

Furthermore, increasing the adoption of novel drug delivery systems and rising prevalence of infectious disease cases are also expected to fuel the life science tools market in the region over the forecast period.

Competitive Landscape

The Life Science Tools Market is moderately competitive. The market players adopted strategies such as product approval and launches, acquisition, partnerships, and agreements. For instance, in 2019, Thermo Fisher Scientific, Inc., and Owlstone Medical entered into an agreement Under which, both the companies will integrate Thermo’s Q Exactive GC Hybrid Quadrupole-Orbitrap MassSpectrometer into Owlstone Medical’s Breath Biopsy platform. Some of the market players include Becton, Dickinson and Company, Agilent Technologies, Illumina, Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Merck KGaA, GE Healthcare, Bruker QIAGEN and others.

Reasons to Purchase this report:

The market estimate (ME) sheet in Excel format

3 months of analyst support

For sample report please visit : https://www.statzyreports.com/report/sr497993/life-science-tools-market
Contact Us:
Poojan Dogra
Public Relations Manager
Email : [email protected]
Email : [email protected]
(IN) - +918484035727
(US) - +1415-871-0483
Website : www.statzyreports.com